Chimerix (CMRX) Stock Chart & Stock Price History → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free CMRX Stock Alerts $0.90 +0.01 (+1.12%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Chimerix Stock Price Performance5 Day Performance-2.75%1 Month Performance-15.10%3 Month Performance-3.19%6 Month Performance-7.82%Year-To-Date Performance-6.50%1 Year Performance-22.42% Receive CMRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chimerix and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. CMRX Stock Chart for Sunday, April, 28, 2024 CMRX Chart by TradingView Chimerix Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$0.89$0.90+1.00%$0.91$0.88225,998 shs$80.28 million04/25/2024$0.91$0.89-1.66%$0.94$0.88242,657 shs$79.49 million04/24/2024$0.93$0.91-2.09%$0.93$0.9088,198 shs$80.82 million04/23/2024$0.91$0.93+1.25%$0.94$0.90182,039 shs$82.55 million04/22/2024$0.88$0.91+3.34%$0.93$0.88232,315 shs$81.53 million04/19/2024$0.93$0.88-5.14%$0.94$0.88426,873 shs$78.90 million Get the Latest News and Ratings for CMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chimerix and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$0.90$0.93+3.13%$0.94$0.89360,994 shs$83.17 million04/17/2024$0.92$0.90-1.75%$0.93$0.89484,912 shs$80.65 million04/16/2024$0.91$0.92+0.60%$0.94$0.90309,525 shs$82.08 million04/15/2024$0.96$0.91-4.80%$0.97$0.90506,516 shs$81.59 million04/12/2024$0.99$0.96-2.96%$1.02$0.95234,962 shs$85.70 million04/11/2024$1.00$0.99-0.90%$1.02$0.97203,061 shs$88.32 million04/10/2024$0.99$1.00+0.91%$1.01$0.95382,592 shs$89.12 million04/09/2024$1.00$0.99-1.00%$1.04$0.99151,396 shs$88.32 million04/08/2024$1.03$1.00-2.91%$1.04$1.00192,344 shs$89.21 million04/05/2024$1.04$1.03-0.96%$1.05$0.99210,500 shs$91.89 million04/04/2024$1.04$1.04$1.07$1.03410,587 shs$92.78 million04/03/2024$1.01$1.04+2.97%$1.04$0.99357,984 shs$92.78 million04/02/2024$1.05$1.01-3.81%$1.05$0.99226,856 shs$90.10 million04/01/2024$1.06$1.05-0.94%$1.06$1.00319,297 shs$93.67 million03/29/2024$1.06$1.06$1.09$1.01377,228 shs$94.56 million03/28/2024$1.01$1.06+4.95%$1.09$1.01370,388 shs$94.56 million03/27/2024$0.99$1.01+2.02%$1.04$0.99286,692 shs$90.10 million03/26/2024$0.98$0.99+0.56%$1.01$0.97125,561 shs$88.32 million03/25/2024$1.00$0.98-1.53%$1.01$0.96354,407 shs$87.83 million03/22/2024$0.96$1.00+4.58%$1.01$0.93504,895 shs$89.19 million03/21/2024$0.99$0.96-3.43%$1.00$0.94311,744 shs$85.29 million03/20/2024$0.96$0.99+3.13%$0.99$0.92701,847 shs$88.32 million03/19/2024$1.10$0.96-12.73%$1.12$0.912.73 million shs$85.64 million03/18/2024$1.15$1.10-4.35%$1.17$1.10223,979 shs$98.13 million03/15/2024$1.14$1.15+0.88%$1.17$1.12281,037 shs$102.59 million03/14/2024$1.17$1.14-2.56%$1.19$1.10196,990 shs$101.70 million03/13/2024$1.18$1.17-0.85%$1.24$1.17305,345 shs$104.38 million03/12/2024$1.24$1.18-4.84%$1.26$1.18184,228 shs$105.27 million03/11/2024$1.26$1.24-1.59%$1.29$1.23258,492 shs$110.62 million03/08/2024$1.26$1.26$1.30$1.26285,198 shs$112.41 million03/07/2024$1.25$1.26+0.80%$1.27$1.23312,561 shs$112.41 million03/06/2024$1.21$1.25+3.31%$1.26$1.19401,006 shs$111.51 million03/05/2024$1.18$1.21+2.54%$1.22$1.17422,024 shs$107.94 million03/04/2024$1.17$1.18+0.85%$1.21$1.15562,536 shs$105.27 millionHis win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story.03/01/2024$1.15$1.17+1.74%$1.22$1.10714,373 shs$104.00 million02/29/2024$1.24$1.15-7.26%$1.30$1.15642,114 shs$102.22 million02/28/2024$1.21$1.24+2.90%$1.30$1.19649,893 shs$110.22 million02/27/2024$1.19$1.21+1.26%$1.22$1.18460,021 shs$107.11 million02/26/2024$1.18$1.19+0.85%$1.21$1.17361,862 shs$105.78 million02/23/2024$1.18$1.18$1.20$1.16216,986 shs$104.89 million02/22/2024$1.19$1.18-0.84%$1.22$1.14389,316 shs$104.89 million02/21/2024$1.22$1.19-2.46%$1.24$1.14428,394 shs$105.78 million02/20/2024$1.15$1.22+6.09%$1.27$1.16991,335 shs$108.45 million02/19/2024$1.15$1.15$1.16$1.04744,700 shs$102.22 million02/16/2024$1.04$1.15+10.58%$1.16$1.04744,114 shs$102.22 million02/15/2024$1.05$1.04-0.95%$1.07$1.02483,349 shs$92.45 million02/14/2024$1.03$1.05+1.94%$1.06$1.01407,622 shs$93.33 million02/13/2024$1.05$1.03-1.90%$1.07$1.00835,774 shs$91.56 million02/12/2024$0.93$1.05+12.90%$1.10$0.992.46 million shs$93.33 million02/09/2024$0.91$0.93+2.19%$0.93$0.90217,388 shs$82.67 million02/08/2024$0.92$0.91-0.85%$0.92$0.89153,853 shs$80.90 million02/07/2024$0.93$0.92-1.19%$0.94$0.91160,883 shs$81.59 million02/06/2024$0.91$0.93+2.60%$0.93$0.89227,010 shs$82.58 million02/05/2024$0.93$0.91-2.79%$0.93$0.88595,511 shs$80.49 million02/02/2024$0.93$0.93+0.08%$0.94$0.91450,418 shs$82.80 million02/01/2024$0.94$0.93-0.60%$0.94$0.91160,166 shs$82.74 million01/31/2024$0.94$0.94-0.56%$0.95$0.92101,001 shs$83.24 million01/30/2024$0.91$0.94+3.13%$0.96$0.92179,022 shs$83.71 million01/29/2024$0.93$0.91-1.77%$0.95$0.91356,023 shs$81.17 million Related Companies: BioXcel Therapeutics Stock Chart Eton Pharmaceuticals Stock Chart PMV Pharmaceuticals Stock Chart Oncolytics Biotech Stock Chart Affimed Stock Chart Q32 Bio Stock Chart Hookipa Pharma Stock Chart YS Biopharma Stock Chart Spero Therapeutics Stock Chart Clearside Biomedical Stock Chart Receive CMRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chimerix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMRX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingUrgent Nvidia WarningAltimetryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.